ncRNA name
hsa-miR-26b
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
Wee1
Cancer name
Glioblastoma
Cancer site
Brain, Central Nervous System
Treatment type
Chemotherapy
Drug
Temozolomide
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Down
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Notably, overexpression of miR-26b sensitized TR cells to TMZ.
Tissue resource
human glioma cancer cell lines SNB19
human glioma cancer temozolomide-resistant cell lines SNB19 TR
human glioma cancer cell lines T98G
human glioma cancer temozolomide-resistant cell lines T98G TR
Experiment
qRT-PCR,Western blot
Institute
Country
Continent